ISRCTN10684984 · RECRUITING
Collecting high-quality biomaterial from patients with neurodegenerative diseases and controls for diagnostic and prognostic biomarker investigation/validation, therapeutic applications and other research activities
This study collects blood and urine samples from people with Alzheimer's or Parkinson's, plus healthy volunteers. Researchers want to see whether tiny particles in these fluids can help diagnose disease earlier and track its progress. Nobody receives a treatment. Phase isn't specified because this is a sample-collection study, not a drug test.
You may qualify if
- Signed informed consent form
- Adults of any gender, ethnicity or socio-economic group, with any of the mentioned conditions, aged 18 years and above
- Participants who can provide informed consent for taking blood and/or urine as required
- Participants who can have a blood and/or urine sample taken
- Participants who have an established diagnosis of the mentioned neurodegenerative conditions
- First-degree relatives (parents, siblings, children) of patients with any of the mentioned conditions
- Partners/carers and other healthy control volunteers
You're excluded if
- Participants who are currently involved in interventional clinical trials
- Participants with severe intellectual impairment, who would be unable to cooperate and consent
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-12-04
Source: ISRCTN registry, record ISRCTN10684984, retrieved 2026-10-27. Registry text licensed CC BY 4.0.